Beyond guidelines: what do I need to know when dealing with fungal diagnostics?

Applying an approach that layers multiple modalities according to patient risk and specimen type can shorten time-to-diagnosis, reduce false negatives/positives and enable earlier targeted therapy. Integrating these context-aware steps into routine practice and future guideline updates is likely to improve IFI outcomes and optimize antifungal stewardship.